FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/03/082008 [Registered on: 07/03/2025] Trial Registered Prospectively
Last Modified On: 20/08/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group, Placebo Controlled Trial 
Public Title of Study   To study the number of children effected with respiratory allergic disorders and effect of ayurvedic compound Brihat vasavleh and Shadbindu tail nasya reduce the allergic infection in children. Also to study the various factors responsible for the respiratory allergic disorder in children.  
Scientific Title of Study   COMPARATIVE CLINICAL STUDY TO EVALUATE THE EFFICACY OF BRIHAT VASAVLEHA AND SHADBINDU TAIL NASYA IN THE MANAGEMENT OF PRANAVAHA SROTO DUSHTI W.S.R. OF RESPIRATORY ALLERGIC DISORDERS IN CHILDREN 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Nazneen  
Designation  MD Scholar 
Affiliation  Madan Mohan Malviya Government Ayurved College Udaipur, 
Address  PG DEPARTMENT OF KAUMARBHRITYA Madan Mohan Malviya Government Ayurved College Rada ji choraha Udaipur

Udaipur
RAJASTHAN
313001
India 
Phone  8118805346  
Fax    
Email  drnaz696@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Prof Ram Kumar 
Designation  Professor and Head of Department 
Affiliation  Madan Mohan Malviya Government Ayurved College Udaipur, 
Address  PG DEPARTMENT OF KAUMARBHRITYA Madan Mohan Malviya Government Ayurved College Rada ji choraha Udaipur

Udaipur
RAJASTHAN
313001
India 
Phone  8005857838  
Fax    
Email  drbhamuramkumar@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Prof Ram Kumar 
Designation  Professor and Head Of Department  
Affiliation  Madan Mohan Malviya Government Ayurved College Udaipur 
Address  PG DEPARTMENT OF KAUMARBHRITYA Madan Mohan Malviya Government Ayurved College Rada ji choraha Udaipur

Udaipur
RAJASTHAN
313001
India 
Phone  8005857838  
Fax    
Email  drbhamuramkumar@gmail.com  
 
Source of Monetary or Material Support  
Madan Mohan Malviya Government Ayurved College , Rada ji chouraha, District- Udaipur, Rajasthan, India pin code- 313001 
 
Primary Sponsor  
Name  Madan Mohan Malviya Government Ayurved College Udaipur 
Address  Madan Mohan Malviya Government Ayurved College Rada ji chouraha, District -Udaipur, Rajasthan, India Pin Code-313001 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Nazneen  MMMGA Hospital rada ji choraha and govt ayurved hospital motichohtta  PG DEPARTMENT OF KAUMARBHRITYA madan mohan malviya government ayurved college, Rada ji choraha ,Udaipur
Udaipur
RAJASTHAN 
08118805346

drnaz696@gmail.com 
 
Details of Ethics Committee
Modification(s)  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
institutional ethics committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:J069||Acute upper respiratory infection,unspecified. Ayurveda Condition: PRANAVAHASROTODUSHTIH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Brihat Vasavleh, Reference: bhaishajya ratnavali, Route: Oral, Dosage Form: Avleha/Leha/Paka/Raskriya, Dose: 88(mg), Frequency: od, Bhaishajya Kal: Adhobhakta, Duration: 56 Days, anupAna/sahapAna: Yes(details: lukewarm water), Additional Information: Brihat Vasavleh along with shadbindu nasya (pratimarsh nasya) will given 56 days dose- 6 bindu route-nasal
2Comparator ArmDrugClassical(1) Medicine Name: honey syrup, Reference: charak, Route: Oral, Dosage Form: Sharkara/ Syrup, Dose: 5(ml), Frequency: od, Bhaishajya Kal: Adhobhakta, Duration: 56 Days, anupAna/sahapAna: No, Additional Information: placebo (honey syrup) along with shadbindu tail nasya
 
Inclusion Criteria  
Age From  6.00 Year(s)
Age To  14.00 Year(s)
Gender  Both 
Details  Children whose parents are willing to give consent/assent for clinical trial.
Children having cardinal features of respiratory allergy.
Children aged between 06 years to 14 years of either sex.
Children with a history of three or more episode within the past year.  
 
ExclusionCriteria 
Details  Children cases of respiratory allergies that are severe and complicated. Children aged below 06 years and above 14 years of either sex.
Children suffering from major systemic illness necessitating long-term treatment.
Children with evidence of malignancy, genetic or congenital anomaly.
Children diagnosed with Tuberculosis, Plural effusion, Emphysema, Lung abscess,
Bronchiectasis, Pleurisy, Nasal polyps etc.
H/o hypersensitivity to any of the trial drug or their ingredient. . 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
to check the effectiveness and efficacy of the drug and procedure in Respiratory Allergic Disorders  56 days 
 
Secondary Outcome  
Outcome  TimePoints 
To compare both the drugs  56 days 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   17/03/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="9"
Days="15" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary    This study is conducted on upper respiratory tract infections on 60 cases through brihat vasavleh and shadbindu tail nasya . To conduct the study two groups will be there 
group A - brihat vasavleh and shadbindu tail nasya
group B- placebo and shadbindu tail nasya

 
Close